Clostebol acetate (BAN) (brand names Macrobin, Steranabol, Alfa-Trofodermin, Megagrisevit), also known as 4-chlorotestosterone 17β-acetate (4-CLTA) or as 4-chloroandrost-4-en-17β-ol-3-one 17β-acetate, is a synthetic, injected anabolic-androgenic steroid (AAS) and a derivative of testosterone that is marketed in Germany and Italy.[1][2][3] It is an androgen ester – specifically, the C17β acetate ester of clostebol (4-chlorotestosterone) – and acts as a prodrug of clostebol in the body.[1][2][additional citation(s) needed] Clostebol acetate is administered via intramuscular injection.[3][4]
Clinical data | |
---|---|
Trade names | Macrobin, Steranabol, Alfa-Trofodermin, Megagrisevit |
Other names | 4-Chlorotestosterone acetate; 4-CLTA; 4-Chloroandrost-4-en-17β-ol-3-one 17β-acetate; NSC-72159 |
Routes of administration | Intramuscular injection |
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
DrugBank |
|
ChemSpider |
|
UNII |
|
KEGG |
|
ChEBI |
|
ChEMBL |
|
CompTox Dashboard (EPA) |
|
ECHA InfoCard | 100.011.565 |
Chemical and physical data | |
Formula | C21H29ClO3 |
Molar mass | 364.91 g·mol−1 |
3D model (JSmol) |
|
| |
|